UniProt ID | 3BP5L_HUMAN | |
---|---|---|
UniProt AC | Q7L8J4 | |
Protein Name | SH3 domain-binding protein 5-like | |
Gene Name | SH3BP5L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 393 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MAELRQVPGGRETPQGELRPEVVEDEVPRSPVAEEPGGGGSSSSEAKLSPREEEELDPRIQEELEHLNQASEEINQVELQLDEARTTYRRILQESARKLNTQGSHLGSCIEKARPYYEARRLAKEAQQETQKAALRYERAVSMHNAAREMVFVAEQGVMADKNRLDPTWQEMLNHATCKVNEAEEERLRGEREHQRVTRLCQQAEARVQALQKTLRRAIGKSRPYFELKAQFSQILEEHKAKVTELEQQVAQAKTRYSVALRNLEQISEQIHARRRGGLPPHPLGPRRSSPVGAEAGPEDMEDGDSGIEGAEGAGLEEGSSLGPGPAPDTDTLSLLSLRTVASDLQKCDSVEHLRGLSDHVSLDGQELGTRSGGRRGSDGGARGGRHQRSVSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | QVPGGRETPQGELRP CCCCCCCCCCCCCCH | 21.39 | 29255136 | |
30 | Phosphorylation | VEDEVPRSPVAEEPG HCCCCCCCCCCCCCC | 20.04 | 30266825 | |
41 | Phosphorylation | EEPGGGGSSSSEAKL CCCCCCCCCCCCCCC | 30.26 | 23663014 | |
42 | Phosphorylation | EPGGGGSSSSEAKLS CCCCCCCCCCCCCCC | 40.95 | 23663014 | |
43 | Phosphorylation | PGGGGSSSSEAKLSP CCCCCCCCCCCCCCH | 33.62 | 23663014 | |
44 | Phosphorylation | GGGGSSSSEAKLSPR CCCCCCCCCCCCCHH | 43.45 | 23663014 | |
49 | Phosphorylation | SSSEAKLSPREEEEL CCCCCCCCHHHHHHC | 22.62 | 29255136 | |
112 | Ubiquitination | HLGSCIEKARPYYEA CHHHHHHHHHHHHHH | 29.77 | - | |
142 | Phosphorylation | LRYERAVSMHNAARE HHHHHHHHHHHHHHH | 17.22 | 27251275 | |
143 | Sulfoxidation | RYERAVSMHNAAREM HHHHHHHHHHHHHHH | 1.96 | 30846556 | |
213 | Ubiquitination | ARVQALQKTLRRAIG HHHHHHHHHHHHHHC | 50.83 | - | |
233 | Phosphorylation | FELKAQFSQILEEHK HHHHHHHHHHHHHHH | 12.30 | 28857561 | |
254 | Ubiquitination | EQQVAQAKTRYSVAL HHHHHHHHHHHHHHH | 22.81 | - | |
334 | Phosphorylation | APDTDTLSLLSLRTV CCCCCHHHHHHHHHH | 29.38 | 25921289 | |
337 | Phosphorylation | TDTLSLLSLRTVASD CCHHHHHHHHHHHHH | 22.54 | 25921289 | |
340 | Phosphorylation | LSLLSLRTVASDLQK HHHHHHHHHHHHHHH | 26.22 | 30266825 | |
343 | Phosphorylation | LSLRTVASDLQKCDS HHHHHHHHHHHHCCC | 34.22 | 29255136 | |
350 | Phosphorylation | SDLQKCDSVEHLRGL HHHHHCCCHHHHCCC | 38.58 | 23401153 | |
358 | Phosphorylation | VEHLRGLSDHVSLDG HHHHCCCCCCEEECC | 28.61 | 29255136 | |
362 | Phosphorylation | RGLSDHVSLDGQELG CCCCCCEEECCCCCC | 19.81 | 29255136 | |
370 | Phosphorylation | LDGQELGTRSGGRRG ECCCCCCCCCCCCCC | 34.00 | 23927012 | |
378 | Phosphorylation | RSGGRRGSDGGARGG CCCCCCCCCCCCCCC | 31.13 | 26699800 | |
390 | Phosphorylation | RGGRHQRSVSL---- CCCCCCCCCCC---- | 14.97 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of 3BP5L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 3BP5L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 3BP5L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BICD1_HUMAN | BICD1 | physical | 28514442 | |
THG1_HUMAN | THG1L | physical | 28514442 | |
TNKS1_HUMAN | TNKS | physical | 28514442 | |
TNKS2_HUMAN | TNKS2 | physical | 28514442 | |
FBW1A_HUMAN | BTRC | physical | 28514442 | |
MYPT1_HUMAN | PPP1R12A | physical | 28514442 | |
HEXI1_HUMAN | HEXIM1 | physical | 28514442 | |
MIPO1_HUMAN | MIPOL1 | physical | 28514442 | |
FBW1B_HUMAN | FBXW11 | physical | 28514442 | |
CARM1_HUMAN | CARM1 | physical | 28514442 | |
FL2D_HUMAN | WTAP | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; SER-350 ANDSER-362, AND MASS SPECTROMETRY. |